AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Effective tax rate (%)

Immuno-Biological Laboratories Co., Ltd.【JP:4570】

Market cap
¥15.2B
P/E ratio
57.4x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Mar 31, 2025-18.7-62.26%
Mar 31, 2024-49.5+711.15%
Mar 31, 2023-6.1+72.18%
Mar 31, 2022-3.5+34.19%
Mar 31, 2021-2.6+89.95%
Mar 31, 2020-1.4-34.75%
Mar 31, 2019-2.1+49.76%
Mar 31, 2018-1.4+193.69%
Mar 31, 2017-0.5-83.26%
Mar 31, 2016-2.9-16.72%
Mar 31, 2015-3.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)